April 20, 2026 11:50–12:08 PM
Broadway 3
At Myosin Therapeutics, we’re tackling aggressive, treatment-resistant cancers by targeting a completely new frontier in cancer biology—the molecular nanomotors that power cancer cell movement, invasion, and survival.
